In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cochlear Ltd.

Latest From Cochlear Ltd.

Soterios Topical Could Take On JAK Class In Alopecia Areata

The UK biotech unveils Phase II data showing an ability to reduce severity of mild-to-moderate AA, with full hair restoration in some patients. If approved, STS-01 will compete with Olumiant and Litfulo.

Clinical Trials Drug Approval Standards

Senate Work On Biosecurity Issues Continues Even As House Is Current Focus Of Legislative Activity

US FDA Principal Deputy Commissioner Namandjé Bumpus recently attended a biotech-themed roundtable with the Senate Select Committee on Intelligence and national security officials as Congress’ pulls the FDA into its worries about Chinese influence of the pharma industry.

China Legislation

Syngene Chief: Large Cap Biopharma Taking China 'Rotation' More Seriously

A material shift in China derisking discussions by big biopharma against the backdrop of the proposed US BIOSECURE Bill is seen presenting opportunities for Syngene, though the tight US biotech funding environment dampened demand for the Indian CRDMO’s R&D services in Q4.

Commercial Financing

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

Approvals FDA
See All

Company Information

  • Industry
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Other Names / Subsidiaries
    • Cochlear Americas
    • Entifie Medical Systems Inc.
    • Nobel Biocare USA
    • Cochlear Bone Anchored Solutions, Sycle, LLC
    • Cochlear Malaysia Sdn. Bhd.